Cargando…

Monoaminergic and Kynurenergic Characterization of Frontotemporal Dementia and Amyotrophic Lateral Sclerosis in Cerebrospinal Fluid and Serum

Exploring the neurochemical continuum between frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) with respect to monoamines and kynurenines in cerebrospinal fluid (CSF) and serum, may be useful to identify possible new research/therapeutic targets. Hence, we analysed monoamines an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Janssens, Jana, Vermeiren, Yannick, van Faassen, Martijn, van der Ley, Claude, Kema, Ido P., De Deyn, Peter P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2020
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7162843/ https://www.ncbi.nlm.nih.gov/pubmed/32130630 http://dx.doi.org/10.1007/s11064-020-03002-5

Ejemplares similares

Brain Kynurenine Pathway Metabolite Levels May Reflect Extent of Neuroinflammation in ALS, FTD and Early Onset AD
por: Heylen, Annelies, et al.
Publicado: (2023)

The monoaminergic footprint of depression and psychosis in dementia with Lewy bodies compared to Alzheimer’s disease
por: Vermeiren, Yannick, et al.
Publicado: (2015)

Age‐ and disease‐specific changes of the kynurenine pathway in Parkinson’s and Alzheimer’s disease
por: Sorgdrager, Freek J. H., et al.
Publicado: (2019)

Serotonergic Dysfunction in Amyotrophic Lateral Sclerosis and Parkinson's Disease: Similar Mechanisms, Dissimilar Outcomes
por: Vermeiren, Yannick, et al.
Publicado: (2018)

Cerebrospinal fluid and serum MHPG improve Alzheimer's disease versus dementia with Lewy bodies differential diagnosis
por: Janssens, Jana, et al.
Publicado: (2018)

The Anaesthetic Biobank of Cerebrospinal fluid: a unique repository for neuroscientific biomarker research
por: Tigchelaar, Celien, et al.
Publicado: (2021)

Genotyping and Plasma/Cerebrospinal Fluid Profiling of a Cohort of Frontotemporal Dementia–Amyotrophic Lateral Sclerosis Patients
por: Bourbouli, Mara, et al.
Publicado: (2021)

In Matrix Derivatization Combined with LC-MS/MS Results in Ultrasensitive Quantification of Plasma Free Metanephrines and Catecholamines
por: van Faassen, Martijn, et al.
Publicado: (2020)

Monoaminergic impairment in Down syndrome with Alzheimer's disease compared to early-onset Alzheimer's disease
por: Dekker, Alain D., et al.
Publicado: (2017)

CCNF mutations in amyotrophic lateral sclerosis and frontotemporal dementia
por: Williams, Kelly L., et al.
Publicado: (2016)

Susceptible genes and disease mechanisms identified in frontotemporal dementia and frontotemporal dementia with Amyotrophic Lateral Sclerosis by DNA-methylation and GWAS
por: Taskesen, E., et al.
Publicado: (2017)

Concentration gradients of monoamines, their precursors and metabolites in serial lumbar cerebrospinal fluid of neurologically healthy patients determined with a novel LC–MS/MS technique
por: Tigchelaar, Celien, et al.
Publicado: (2023)

Expanding the genetics of amyotrophic lateral sclerosis and frontotemporal dementia
por: Schymick, Jennifer C, et al.
Publicado: (2012)

Is amyotrophic lateral sclerosis/frontotemporal dementia an autophagy disease?
por: Deng, Zhiqiang, et al.
Publicado: (2017)

Multifaceted Genes in Amyotrophic Lateral Sclerosis-Frontotemporal Dementia
por: Ranganathan, Ramya, et al.
Publicado: (2020)

The Overlapping Genetics of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
por: Abramzon, Yevgeniya A., et al.
Publicado: (2020)

TDP-43 and Inflammation: Implications for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
por: Bright, Fiona, et al.
Publicado: (2021)

Author Correction: Susceptible genes and disease mechanisms identified in frontotemporal dementia and frontotemporal dementia with Amyotrophic Lateral Sclerosis by DNA-methylation and GWAS
por: Taskesen, E., et al.
Publicado: (2018)

Fgf3 is crucial for the generation of monoaminergic cerebrospinal fluid contacting cells in zebrafish
por: Reuter, Isabel, et al.
Publicado: (2019)

An antibody-free LC-MS/MS method for the quantification of intact insulin-like growth factors 1 and 2 in human plasma
por: Pratt, Mark S., et al.
Publicado: (2021)

Cerebrospinal fluid biomarkers predict frontotemporal dementia trajectory
por: Ljubenkov, Peter A., et al.
Publicado: (2018)

Cerebellar Integrity in the Amyotrophic Lateral Sclerosis - Frontotemporal Dementia Continuum
por: Tan, Rachel H., et al.
Publicado: (2014)

Frontotemporal Dementia in Amyotrophic Lateral Sclerosis: From Rarity to Reality?
por: Orsini, Marco, et al.
Publicado: (2016)

The role of hnRNPs in frontotemporal dementia and amyotrophic lateral sclerosis
por: Bampton, Alexander, et al.
Publicado: (2020)

Cognition and behaviour in frontotemporal dementia with and without amyotrophic lateral sclerosis
por: Saxon, Jennifer A, et al.
Publicado: (2020)

Therapeutic Potential of Polyphenols in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
por: Novak, Valentina, et al.
Publicado: (2021)

Editorial: Multifaceted Genes in Amyotrophic Lateral Sclerosis-Frontotemporal Dementia
por: Conforti, Francesca Luisa, et al.
Publicado: (2021)

Biomarker discovery and development for frontotemporal dementia and amyotrophic lateral sclerosis
por: Katzeff, Jared S., et al.
Publicado: (2022)

Protein Quality Control and the Amyotrophic Lateral Sclerosis/Frontotemporal Dementia Continuum
por: Shahheydari, Hamideh, et al.
Publicado: (2017)

Residual endogenous corticosteroid production in patients with adrenal insufficiency
por: Vulto, Annet, et al.
Publicado: (2019)

Short tandem repeat expansions in sporadic amyotrophic lateral sclerosis and frontotemporal dementia
por: Henden, Lyndal, et al.
Publicado: (2023)

Amnesia in Frontotemporal Dementia with Amyotrophic Lateral Sclerosis, Masquerading Alzheimer's Disease
por: Yamanami-Irioka, A., et al.
Publicado: (2011)

Eating peptides: biomarkers of neurodegeneration in amyotrophic lateral sclerosis and frontotemporal dementia
por: Ahmed, Rebekah M., et al.
Publicado: (2019)

The Role of VCP Mutations in the Spectrum of Amyotrophic Lateral Sclerosis—Frontotemporal Dementia
por: Scarian, Eveljn, et al.
Publicado: (2022)

Neurofilament Light Chain as Biomarker for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
por: Verde, Federico, et al.
Publicado: (2021)

ANXA11 mutations are associated with amyotrophic lateral sclerosis–frontotemporal dementia
por: Wang, Yu, et al.
Publicado: (2022)

Oxytocin in Huntington’s disease and the spectrum of amyotrophic lateral sclerosis-frontotemporal dementia
por: Bergh, Sofia, et al.
Publicado: (2022)

Rapidly Progressive Frontotemporal Dementia With Amyotrophic Lateral Sclerosis in an Elderly Female
por: Sweedan, Yazeed G, et al.
Publicado: (2022)

MicroRNA signatures in genetic frontotemporal dementia and amyotrophic lateral sclerosis
por: Kmetzsch, Virgilio, et al.
Publicado: (2022)

Distinct hypothalamic involvement in the amyotrophic lateral sclerosis-frontotemporal dementia spectrum
por: Tse, Nga Yan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_k3bem5rjvhfaurnluavvf8kska